Timing of miscarriage medication for early pregnancy loss
Part of Women’s health & pregnancy clinical trials.
This study compares two different time intervals between taking two medications (mifepristone and misoprostol) to manage an early pregnancy loss (miscarriage). The goal is to find the best timing to help the body complete the miscarriage safely and effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with an early pregnancy loss (the pregnancy has stopped growing and there is no heartbeat).
- You are able to give informed consent (understand and agree to participate).
- You are willing to follow all study procedures and attend a follow-up visit at the clinic.
- You have access to a device with text or email capability (for communication).
- You can read and understand English.
- You are not allergic to mifepristone or misoprostol, and you do not have any condition that makes these medications unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of taking the abortion pill misoprostol to find out which is more effective and acceptable for people ending an early pregnancy (up to 11 weeks). You would receive standard care and help doctors learn how to improve early abortion options.
This study compares two different medicines (given vaginally or by mouth) to help complete a miscarriage or missed abortion in the first weeks of pregnancy. It aims to find which method works better and is safer for women.
This trial tests two different medicines (Mifepristone vs Misoprostol) to see which works better for ending a pregnancy in the second trimester (12–16 weeks). It is for people who are pregnant with one baby and have no major health issues that could affect safety.
This trial compares two different medication approaches to help your body complete a silent miscarriage, rather than needing surgery. One uses a hormone-balancing pill (letrozole) and the other uses a combination of two medicines (mifepristone and misoprostol). The goal is to find which is more effective and safer for you.
This study tests whether taking letrozole (a hormone-modifying drug) before misoprostol (a medication that helps empty the uterus) can shorten the time needed to complete a missed miscarriage. It may help make the process faster and more effective.
This trial tests whether taking an aromatase inhibitor (letrozole) before misoprostol helps complete a miscarriage more effectively. It may offer a treatment option for people with a missed or early pregnancy loss.
Hear when a new Early Pregnancy Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.